Ras inhibitors combination therapy

TW202631147APending Publication Date: 2026-08-01ERASCA INC
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
ERASCA INC
Filing Date
2025-11-14
Publication Date
2026-08-01

Smart Images

  • Figure TWG2TA001071140_001
    Figure TWG2TA001071140_001
  • Figure TWG2TA001071140_002
    Figure TWG2TA001071140_002
Patent Text Reader

Abstract

The present disclosure relates generally to the use of a combination of a Pan-RAS and a KRAS inhibitor for treating cancer, specifically solid tumors.
Need to check novelty before this filing date? Find Prior Art